These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 35260509)

  • 1. Functional tumour volume and peritoneal carcinomatosis to identify suitable candidates for cytoreductive surgery in ovarian carcinoma: abridged secondary publication.
    Lee EYP; Hui ESK; Ngan HYS
    Hong Kong Med J; 2022 Feb; 28 Suppl 1(1):14-16. PubMed ID: 35260509
    [No Abstract]   [Full Text] [Related]  

  • 2. Functional tumour burden of peritoneal carcinomatosis derived from DWI could predict incomplete tumour debulking in advanced ovarian carcinoma.
    Lee EYP; An H; Perucho JAU; Chiu KWH; Hui ES; Chu MMY; Ngan HYS
    Eur Radiol; 2020 Oct; 30(10):5551-5559. PubMed ID: 32405751
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Protocol for the examination of surgical specimens from patients with peritoneal carcinomatosis originating in ovary, fallopian tube and peritoneum].
    Medina Medina C; Gaona Morales J; Roselló-Sastre E; Delgado Barriga K; Escrig Sos J; Herráiz Roda JL; Llueca Abellá JA;
    Rev Esp Patol; 2018; 51(4):216-223. PubMed ID: 30269772
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular Imaging of Peritoneal Carcinomatosis in Ovarian Carcinoma.
    Lee EYP; An H; Tse KY; Khong PL
    AJR Am J Roentgenol; 2020 Aug; 215(2):305-312. PubMed ID: 32551907
    [No Abstract]   [Full Text] [Related]  

  • 5. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in the treatment of peritoneal carcinomatosis: initial experience in Oaxaca, Mexico.
    García-Matus R; Hernández-Hernández CA; Leyva-García O; Vásquez-Ciriaco S; Flores-Ayala G; Navarro-Hernández Q; Pérez-Bustamante G; Valencia-Mijares NM; Esquivel J
    Am Surg; 2012 Sep; 78(9):942-6. PubMed ID: 22964201
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of (18)F-FDG PET/CT in the preoperative evaluation of patients diagnosed with peritoneal carcinomatosis of ovarian origin, candidates to cytoreduction and hipec. A pending issue.
    Lopez-Lopez V; Cascales-Campos PA; Gil J; Frutos L; Andrade RJ; Fuster-Quiñonero M; Feliciangeli E; Gil E; Parrilla P
    Eur J Radiol; 2016 Oct; 85(10):1824-1828. PubMed ID: 27666623
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of ultra-radical surgery in the management of patients with stage IIIC and IV epithelial ovarian, fallopian tube, and peritoneal cancer.
    Turnbull HL; Akrivos N; Wemyss-Holden S; Maiya B; Duncan TJ; Nieto JJ; Burbos N
    Arch Gynecol Obstet; 2017 Mar; 295(3):681-687. PubMed ID: 27995370
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and validation of a risk-calculator for adverse perioperative outcomes for women with ovarian cancer.
    Cham S; Chen L; St Clair CM; Hou JY; Tergas AI; Melamed A; Ananth CV; Neugut AI; Hershman DL; Wright JD
    Am J Obstet Gynecol; 2019 Jun; 220(6):571.e1-571.e8. PubMed ID: 30771346
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative clinicopathological and cytomorphological analyses of peritoneal carcinomatosis associated with metastatic breast carcinoma and primary peritoneal/ovarian carcinoma in patients with a history of breast carcinoma.
    Na K; Lee JY; Sung JY; Kim GM; Koo JS; Kim HS
    Virchows Arch; 2018 Aug; 473(2):165-175. PubMed ID: 29926183
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Second-look Surgery Detects Low Volume Recurrent Disease Following Cytoreductive Surgery for Peritoneal Carcinomatosis.
    Matar A; Altoukhi K; Tse A; Sohn J; Alzahrani N; Morris DL
    Anticancer Res; 2022 Feb; 42(2):1001-1006. PubMed ID: 35093900
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surgical treatment of peritoneal carcinomatosis: current treatment modalities.
    Kulu Y; Müller-Stich B; Büchler MW; Ulrich A
    Langenbecks Arch Surg; 2014 Jan; 399(1):41-53. PubMed ID: 24249036
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Total parietal peritonectomy with en bloc pelvic resection for advanced ovarian cancer with peritoneal carcinomatosis.
    Kim HS; Bristow RE; Chang SJ
    Gynecol Oncol; 2016 Dec; 143(3):688-689. PubMed ID: 27743737
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel technique: Carbon dioxide gas-assisted total peritonectomy, diaphragm and intestinal meso stripping in open surgery for advanced ovarian cancer (Çukurova technique).
    Khatib G; Guzel AB; Gulec UK; Vardar MA
    Gynecol Oncol; 2017 Sep; 146(3):674-675. PubMed ID: 28720378
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytoreductive surgery for advanced ovarian cancer.
    Pölcher M; Zivanovic O; Chi DS
    Womens Health (Lond); 2014 Mar; 10(2):179-90. PubMed ID: 24601809
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proposal for selection criteria of secondary cytoreductive surgery in recurrent epithelial ovarian, tubal, and peritoneal cancers.
    Minaguchi T; Satoh T; Matsumoto K; Sakurai M; Ochi H; Onuki M; Oki A; Yoshikawa H
    Int J Clin Oncol; 2016 Jun; 21(3):573-9. PubMed ID: 26475355
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A radical approach to achieve complete cytoreductive surgery improve survival of patients with advanced ovarian cancer.
    Liberale G; Pop CF; Polastro L; Kerger J; Moreau M; Chintinne M; Larsimont D; Nogaret JM; Veys I
    J Visc Surg; 2020 Apr; 157(2):79-86. PubMed ID: 31837942
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Concordance of laparoscopic and laparotomic peritoneal cancer index using a two-step surgical protocol to select patients for cytoreductive surgery in advanced ovarian cancer.
    Angeles MA; Migliorelli F; Del M; Martínez-Gómez C; Daix M; Bétrian S; Gabiache E; Balagué G; Leclerc S; Mery E; Gladieff L; Ferron G; Martinez A
    Arch Gynecol Obstet; 2021 May; 303(5):1295-1304. PubMed ID: 33389113
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for the Treatment of Peritoneal Carcinomatosis: Our Initial Experience.
    Bartoş A; Bartoş D; Raluca S; Mitre C; Hadade A; Iancu I; Cioltean C; Iancu C; Militaru C; Părău A; Breazu C
    Chirurgia (Bucur); 2019; 114(2):222-233. PubMed ID: 31060655
    [No Abstract]   [Full Text] [Related]  

  • 19. Safety and potential benefit of hyperthermic intraperitoneal chemotherapy (HIPEC) in peritoneal carcinomatosis from primary or recurrent ovarian cancer.
    Roviello F; Pinto E; Corso G; Pedrazzani C; Caruso S; Filippeschi M; Petrioli R; Marsili S; Mazzei MA; Marrelli D
    J Surg Oncol; 2010 Nov; 102(6):663-70. PubMed ID: 20721959
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of peritoneal carcinomatosis from ovarian cancer by surgical cytoreduction and hyperthermic intraperitoneal chemotherapy (HIPEC).
    Robella M; Vaira M; Marsanic P; Mellano A; Borsano A; Cinquegrana A; Sottile A; De Simone M
    Minerva Chir; 2014 Feb; 69(1):27-35. PubMed ID: 24675244
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.